FormWeb • coagulation factor Xa recombinant, inactivated-zhzo

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

coagulation factor Xa recombinant, inactivated-zhzo

coagulation factor Xa recombinant, inactivated-zhzo

Non-formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Andexxa	POWDER FOR INJECTION, INTRAVENOUS	100 mg

Comments:

Withdrawn from US market December 2025

Reviewed: 28 Aug 2018 (Andexxa)

Last updated: Jan. 28, 2026

Black Box Warning: Thromboembolic Risks, Ischemic Risks, Cardiac Arrest, and Sudden Deaths

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.